Summary
- Current Price
- As of today, OGN price is $6.56, down -2.24% on
- Current Price All-Time High
- OGN price is currently -83.38% below its historical high of $39.48 set on
- Market Cap
- OGN current market cap is $2B, down -55.51% year-over-year
- PE Ratio
- OGN current PE ratio is 9.15
- Revenue
- OGN current annual revenue is $6.22B, down -2.92% year-over-year
- Next Earnings
- The next earnings release for OGN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Organon & Co. |
| Ticker | NYSE: OGN |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | organon.com |
| Employees | 10,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $6.56 | |
| Price, 1D Change | -2.24% | |
| $2B | ||
| 1.22% | ||
| 9.15 | ||
| 0.92 | ||
| $6B | ||
| Revenue, 1Y Change | -2.92% | |
| $0.72 | ||
| EPS, 1Y Change | -78.49% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.02 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | OGN.V | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.72 | ||
| EPS Estimate | N/A | $3.47 |
| EPS Est. Change | N/A | +383.49% |
| $6.22B | ||
| Revenue Estimate | N/A | $6.17B |
| Revenue Est. Change | N/A | -0.67% |
| Current Price | $6.56 | |
| Price Target | - | $9.00 |
| Price Tgt. Change | - | +37.20% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.11 | $3.33 | -18.86% | |
| $3.76 | $0.72 | -80.95% | |
| $3.47 | N/A | +383.49% | |
| $3.73 | N/A | +419.70% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $6.41B | $6.40B | -0.06% | |
| $6.23B | $6.22B | -0.19% | |
| $6.17B | N/A | -0.67% | |
| $6.22B | N/A | +0.13% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $6.56 | |
| $8.78 | ||
| SMA 200 vs Price | +33.77% | |
| $7.93 | ||
| SMA 50 vs Price | +20.89% | |
| 0.92 | ||
| $0.37 | ||
| 32.49 | ||
| 45.51% | ||
| 62.42% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.02 | |
| Upcoming | N/A | N/A |
| 5.18% | ||
| Total Dividend | $0.34 | |
| $88.00M | ||
| 47.06% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $6.22B | ||
| $0.72 | ||
| $3.31B | ||
| 53.30% | ||
| $1.22B | ||
| 19.63% | ||
| $187.00M | ||
| 3.01% | ||
| $1.57B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 11.70 | ||
| 1.82 | ||
| 1.23 | ||
| - | ||
| 6 | ||
| 1.18 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 9.15 | ||
| 0.27 | ||
| 2.27 | ||
| 6.29 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $752.00M | ||
| $574.00M | ||
| $12.87B | ||
| $4.35B | ||
| $12.12B | ||
| $2.39B | ||
| $8.80B | ||
| $56.00M | ||
| $952.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $6.03B | ||
| $2.09B | ||
| $2.90B | ||
| $0.00 | ||
| $361.00M | ||
| $0.00 | ||
| $238.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $700.00M | ||
| -$390.00M | ||
| -$561.00M | ||
| $192.00M | ||
| $508.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| Barclays | ||
| Morgan Stanley | → | |
| JP Morgan | → | |
| Piper Sandler | → | |
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| Barclays | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with OGN
FAQ
What is the ticker symbol for Organon & Co.?
The ticker symbol for Organon & Co. is NYSE:OGN
Does Organon & Co. pay dividends?
Yes, Organon & Co. pays dividends. The last payment was $0.02, with an ex-dividend date on February 22, 2026
What sector is Organon & Co. in?
Organon & Co. is in the Healthcare sector
What industry is Organon & Co. in?
Organon & Co. is in the General Drug Manufacturers industry
What country is Organon & Co. based in?
Organon & Co. is headquartered in United States
When did Organon & Co. go public?
Organon & Co. initial public offering (IPO) was on May 14, 2021
Is Organon & Co. in the S&P 500?
No, Organon & Co. is not included in the S&P 500 index
Is Organon & Co. in the NASDAQ 100?
No, Organon & Co. is not included in the NASDAQ 100 index
Is Organon & Co. in the Dow Jones?
No, Organon & Co. is not included in the Dow Jones index
When was Organon & Co. last earnings report?
Organon & Co.'s most recent earnings report was on February 12, 2026
When does Organon & Co. report earnings?
The next expected earnings date for Organon & Co. is April 30, 2026
Data Sources & References
- OGN Official Website www.organon.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1821825/000110465926013888/0001104659-26-013888-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1821825/000110465926013888/0001104659-26-013888-index.htm
- OGN Profile on Yahoo Finance finance.yahoo.com/quote/OGN
- OGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ogn